Child Health Imprints (CHIL), a Singapore-based company engaged in neonatal-clinical care, has raised $2.4 million (approximately Rs 17.01 crore at current exchange rates) in a pre-Series A funding round.
The round was led by HealthXCapital, a healthcare-focussed investor. Other investors that participated in the round include Enterprise SG and high net-worth individuals.
The company will use the funds to expand its integrated neonatal intensive care unit (NICU) care services in the Asia-Pacific region, and obtaining international regulatory approvals, CHIL said in a statement.
Harpreet Singh, co-founder and chief executive at CHIL, said the firm was aiming to improve neonatal safety rates across countries where it operates. “The company will also develop inroads into more advanced neonatal ecosystems to bring their best clinical practices to other markets across the world,” Singh said.
The startup is currently running 25 NICUs across hospitals in India including Apollo Hospitals in four cities, New Delhi’s Sir Gangaram Hospital. It is also looking to further expansion in India, and abroad including Indonesia, Japan and South Korea.